Home  |  Speakers  |  Agenda  |  Venue  |  Delegates  |  Sponsors |  Media  |  Register


Oligonucleotide & Peptide Based Therapeutics Congress

Global Engage is pleased to announce, as part of both their Genomic and Biologic series of events, the Oligonucleotide & Peptide Based Therapeutics Congress, which will be held on 18-19 November 2013 in San Diego, CA, USA.

The Oligonucleotide and Peptide Therapeutic market is growing rapidly.  The increase of drug development programs in the sector as well as advancements in delivery solutions, away from injectables, has meant manufacturing production is increasing tremendously too.

Attracting experts working in all areas of Oligonucleotide and Peptide research and manufacture the conference will examine the latest discovery, pre-clinical and clinical based research, alongside cutting edge manufacturing  and delivery solutions therefore helping with the continued advancement in development, reduction in cost, and commercialization of these type of drugs.

Held on the West Coast to enable easy access for US based attendees, as well as attracting representatives from the growing Asian market - the conference will provide an interactive networking forum by supplying a vibrant exhibition room full of manufacturing and technology providers showcasing their solutions, expert led case study presentations and interactive Q&A panel discussions examining topics through the four separate tracks outlined below.

Day One Stream One - Oligonucleotide Therapeutics R&D
Day One Stream Two - Peptide Therapeutics R&D
Day Two Stream One - Advances in Process Development & Manufacturing for Oligonucleotide and Peptides
Day Two Stream Two - Oligonucleotide & Peptide Delivery Strategies

For a more detailed synopsis please visit the Agenda page or download the conference agenda which will be available shortly.

The speaker panel includes:


Keith
                          JamesKeith James,
President
Ferring Research Institute  &
Senior Vice-President R&D, Ferring Pharmaceuticals

Neil
                            GibsonNeil Gibson
Chief Scientific Officer
Regulus Therapeutics



 
David
                          LewisDavid Lewis
Vice President, Biology
Arrowhead Research Corporation



Elena
                            FeinsteinElena Feinstein
Chief Scientific Officer
Quark Pharmaceuticals



Get the latest news and updates:

 

 
 
 
We hate spam and will never sell your details. 



Oligos and
                  Peptide Newsletter



Register Now








For further information please contact;

Steve Hambrook
Conference Director

steve@globalengage.co.uk
+44 (0) 1865 849841




© Global Engage  2013